|Articles|April 12, 2016
OmniComm Penetrates Growing Israeli Life Sciences Market
OmniComm has announced the signing of an agreement with Medistat Ltd.
Advertisement
OmniComm has announced the signing of an agreement with Medistat Ltd., headquartered in Tel Aviv, Israel; to address the clinical trial needs of the growing Israeli life sciences sector. Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
2
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
3
Breaking the Efficacy Ceiling in IBD and Beyond
4
The Career They Didn't Train For: Rethinking Early-Career Burnout in Clinical Research
5